Systemic lupus erythematosus with membranous glomerulonephritis and transverse myelitis associated with anabolic steroid use.
This report describes a 29-year-old bodybuilder taking anabolic steroids who presented with urinary retention, arthralgias, and peripheral edema, subsequently developed acute lower-extremity paralysis, and was diagnosed as having transverse myelitis and membranous glomerulonephritis secondary to systemic lupus erythematosus (SLE). The association of anabolic steroid use and hyperprolactinemia, and their possible link to the development of SLE, are reviewed.
Radis
C D
CD
Rheumatology Associates, Portland, Maine 04102, USA.
Callis
K P
KP
D000328:Adult; D045930:Anabolic Agents / Q000009:adverse effects*; D015433:Glomerulonephritis, Membranous / Q000139:chemically induced*; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000209:etiology*; D008279:Magnetic Resonance Imaging; D008297:Male; D009188:Myelitis, Transverse / Q000139:chemically induced* / Q000175:diagnosis; D009277:Nandrolone / Q000009:adverse effects*; D010911:Pituitary Neoplasms / Q000150:complications / Q000175:diagnosis; D015175:Prolactinoma / Q000150:complications / Q000175:diagnosis; D014891:Weight Lifting
D045930:Anabolic Agents; D009277:Nandrolone